In a fight against the novel coronavirus, researchers have revealed that COVID-19 may increase the risk of blot clots in women who are pregnant or taking estrogen with birth control or hormone replacement therapy. According to the researchers, the novel coronavirus, SARS-CoV-2, has proven unusual with respect to the spectrum of its pathological effects. “In addition to the damage inflicted on the lungs, kidneys, heart and other organ systems, reports have emerged of hypercoagulable states in patients hospitalized with COVID-19,” said study author Daniel I. Spratt from the Tufts University in the US.
This news content is a computer generated summarized version of the original article and the authenticity of the original content has not been verified. Please click on the View Article button to refer to the actual content.